Literature DB >> 21257797

Standardized visual predictive check versus visual predictive check for model evaluation.

Diane D Wang1, Shuzhong Zhang.   

Abstract

The visual predictive check (VPC) is a commonly used approach in model evaluation. However, it may not be feasible to conduct a VPC, or the results of a VPC could be misleading in certain situations. The objectives of the present study were to (1) examine the performance and applicability of the VPC and (2) propose the standardized visual predictive check (SVPC) as an alternative/complementary approach to the VPC. The difference between the SVPC and normalized prediction distribution error (npde) as visual tools for model evaluation is also discussed. The results of the simulation studies demonstrate that the VPC is not appropriate when stratification of covariate(s) in a model is difficult or arbitrary and may not be feasible when study design varies during a study/among participants. The SVPC addresses these issues by displaying the percentiles (P(i,j)) of each participant's observations in the marginal distribution of the corresponding model-simulated endpoints as a function of time (or any covariate of interest) based on that participant's own design template. Since the calculation of P(i,j) factors out subject-specific design features, the difference between observation and simulated values is only caused by misspecification of the structure model and/or inadequate estimation of random effect. Thus, the SVPC can be used in any situation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21257797     DOI: 10.1177/0091270010390040

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  37 in total

1.  Automatic data binning for improved visual diagnosis of pharmacometric models.

Authors:  Marc Lavielle; Kevin Bleakley
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-10-26       Impact factor: 2.745

2.  Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R.

Authors:  Michael N Neely; Michael G van Guilder; Walter M Yamada; Alan Schumitzky; Roger W Jelliffe
Journal:  Ther Drug Monit       Date:  2012-08       Impact factor: 3.681

3.  Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.

Authors:  Xuemei Wu; Raman Venkataramanan; Ryan M Rivosecchi; Chenxiao Tang; Rachel V Marini; Ryan K Shields; Cornelius J Clancy; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

4.  Why should prediction discrepancies be renamed standardized visual predictive check?

Authors:  Emmanuelle Comets; Karl Brendel; France Mentré
Journal:  J Clin Pharmacol       Date:  2011-09-10       Impact factor: 3.126

5.  Quantitative characterization of circadian rhythm of pulmonary function in asthmatic patients treated with inhaled corticosteroids.

Authors:  Di Zhou; Hongshan Li; Yaning Wang; Guenther Hochhaus; Vikram Sinha; Liang Zhao
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-06-23       Impact factor: 2.745

6.  A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy.

Authors:  Dongwoo Chae; Chung Mo Nam; Joo Hoon Kim; Choong-Kun Lee; Seung-Seob Kim; Hyo Song Kim; Minkyu Jung; Jae Ho Cheong; Hyun Cheol Chung; Sun Young Rha; Kyungsoo Park
Journal:  AAPS J       Date:  2018-05-29       Impact factor: 4.009

7.  Development of population pharmacokinetics model of icotinib with non-linear absorption characters in healthy Chinese volunteers to assess the CYP2C19 polymorphism and food-intake effect.

Authors:  Pei Hu; Jia Chen; Dongyang Liu; Xin Zheng; Qian Zhao; Ji Jiang
Journal:  Eur J Clin Pharmacol       Date:  2015-05-21       Impact factor: 2.953

8.  Population pharmacokinetics of intravenous busulfan in children: revised body weight-dependent NONMEM® model to optimize dosing.

Authors:  Christian Diestelhorst; Joachim Boos; Jeannine S McCune; Georg Hempel
Journal:  Eur J Clin Pharmacol       Date:  2014-05-09       Impact factor: 2.953

9.  Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach.

Authors:  Mohamed A Kamal; Kayla Yi Ting Lien; Richard Robson; Vishak Subramoney; Barry Clinch; Craig R Rayner; Leonid Gibiansky
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

10.  Population pharmacokinetics of escalating doses of caspofungin in a phase II study of patients with invasive aspergillosis.

Authors:  Gudrun Würthwein; Oliver A Cornely; Mirjam N Trame; Janne J Vehreschild; Maria J G T Vehreschild; Fedja Farowski; Carsten Müller; Joachim Boos; Georg Hempel; Michael Hallek; Andreas H Groll
Journal:  Antimicrob Agents Chemother       Date:  2013-01-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.